March 23, 2018 / 12:53 PM / 8 months ago

BRIEF-CHMP Recognizes That Amgen's Repatha Prevents Heart Attacks And Strokes

March 23 (Reuters) - Amgen Inc:

* AMGEN RECEIVES POSITIVE CHMP OPINION RECOGNIZING THAT REPATHA (EVOLOCUMAB) PREVENTS HEART ATTACKS AND STROKES

* AMGEN INC - RECOMMENDED LABEL INCLUDES NEW INDICATION BASED ON REPATHA CARDIOVASCULAR OUTCOMES STUDY Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below